SCHEMBL5114797

SCHEMBL5114797

NC(=O)c1sc2cc(N3CCOCC3)cc(F)c2c1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.50
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAOA P21397 1/20 0.41
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CDK8 P49336 4/20 0.39
CDK19 Q9BWU1 3/20 0.39
PARP1 P09874 1/20 0.38
LRRK2 Q5S007 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5107609 0.84 IKBKB (0.47) IKBKBCDK8CDK19
SCHEMBL5114136 0.82 IKBKB (0.50) IKBKBKDM4EALDH1A1GAAHPGD
SCHEMBL5110372 0.80 IKBKB (0.47) IKBKBKDM4EALDH1A1GAAHPGD
SCHEMBL2769424 0.77 PARP1 (0.49) KDM4EALDH1A1HPGDMAOANPC1
SCHEMBL5109107 0.74 PARP1 (0.41) IKBKBCDK8PARP1BTK
SCHEMBL2376896 0.72 LGMN (0.49) KDM4EALDH1A1GAAMAOANPC1
SCHEMBL19769168 0.72 IKBKB (0.51) IKBKBKDM4EALDH1A1GAAHPGD
SCHEMBL5114160 0.72 CASP7 (0.42) IKBKBKDM4EALDH1A1MAPTJAK2
SCHEMBL3510550 0.71 JAK2 (0.44) IKBKBALDH1A1MAOAPARP1LRRK2
SCHEMBL28190265 0.68 PRKDC (0.55) MAPTPARP1JAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329764-B2 Substitute benzothiophene compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2008-02-12 US disclosed
US-7329764-B2 Substitute benzothiophene compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2008-02-12 US disclosed
US-7329764-B2 Substitute benzothiophene compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2008-02-12 US disclosed
EP-1651629-A1 SUBSTITUTED BENZOTHIOPHENE COMPOUNDS AND USES THEREOF BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2006-05-03 EP disclosed
US-20050038104-A1 Substitute benzothiophene compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-02-17 US disclosed
WO-2005012283-A1 SUBSTITUTED BENZOTHIOPHENE COMPOUNDS AND USES THEREOF BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038104-A1 Substitute benzothiophene compounds TST, SULT1E1, LTC4S IKBKB 338/4885KDM4E 2321/4885ALDH1A1 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.